Elixxer Valuation
| ELIXF Stock | USD 0.04 0.02 216.96% |
Elixxer seems to be undervalued based on Macroaxis valuation methodology. Our model computes the value of Elixxer from reviewing the firm fundamentals such as Shares Owned By Insiders of 34.62 %, operating margin of (8.81) %, and Shares Outstanding of 11.35 M as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Elixxer's price fluctuation is out of control at this time. Calculation of the real value of Elixxer is based on 3 months time horizon. Increasing Elixxer's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elixxer pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Elixxer. Since Elixxer is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elixxer Pink Sheet. However, Elixxer's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0355 | Real 0.0451 | Hype 0.04 | Naive 0.0207 |
The real value of Elixxer Pink Sheet, also known as its intrinsic value, is the underlying worth of Elixxer Company, which is reflected in its stock price. It is based on Elixxer's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Elixxer's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Elixxer helps investors to forecast how Elixxer pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elixxer more accurately as focusing exclusively on Elixxer's fundamentals will not take into account other important factors: Elixxer Total Value Analysis
Elixxer is currently anticipated to have takeover price of 9.36 M with market capitalization of 10.14 M, debt of 8.02 M, and cash on hands of 4.22 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Elixxer fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.36 M | 10.14 M | 8.02 M | 4.22 M |
Elixxer Asset Utilization
One of the ways to look at asset utilization of Elixxer is to check how much profit was generated for every dollar of assets it reports. Elixxer shows a negative utilization of assets of -0.031 percent, losing $3.1E-4 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Elixxer shows how discouraging it operates for each dollar spent on its assets.Elixxer Ownership Allocation
The market capitalization of Elixxer is $10.14 Million. Elixxer retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Elixxer Profitability Analysis
Net Loss for the year was (3.66 M) with profit before overhead, payroll, taxes, and interest of 42.41 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Elixxer's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Elixxer and how it compares across the competition.
About Elixxer Valuation
The pink sheet valuation mechanism determines Elixxer's current worth on a weekly basis. Our valuation model uses a comparative analysis of Elixxer. We calculate exposure to Elixxer's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elixxer's related companies.Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada. Elixxer is traded on OTC Exchange in the United States.
8 Steps to conduct Elixxer's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Elixxer's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Elixxer's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Elixxer's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Elixxer's revenue streams: Identify Elixxer's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Elixxer's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Elixxer's growth potential: Evaluate Elixxer's management, business model, and growth potential.
- Determine Elixxer's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Elixxer's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Elixxer Growth Indicators
Investing in growth stocks can be very risky. If the company such as Elixxer does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 11.1 M | |
| Retained Earnings | -66.3 M | |
| Shares Float | 7.5 M |
Complementary Tools for Elixxer Pink Sheet analysis
When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |